ResearcherKyushu UniversityActive in the last 2 years
Shuntaro Tsukamoto
Matched on ORCID iD 0000-0001-9919-7007; OpenAlex author ID A5074209436. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper
Papers 4
- Stromal FAP-targeted 18F-FAPI-74 PET/CT in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2026.07.004↗
- Identification of CLEC10A as a human lectin for pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-025-02404-1↗
- Delivery of a BET protein degrader via a CEACAM6-targeted antibody-drug conjugate inhibits tumour growth in pancreatic cancer models. Co-author DOI 10.1038/s41467-024-46167-1↗
- FOXO3 is essential for CD44 expression in pancreatic cancer cells. Co-author DOI 10.1038/onc.2016.426↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Tatsuya Oda · 2 shared papers, 2025–2026 · strength 0.50
- Osamu Shimomura · 2 shared papers, 2025–2026 · strength 0.50
- Yoshihiro Miyazaki · 2 shared papers, 2025–2026 · strength 0.50
- Hiromitsu Nakahashi · 2 shared papers, 2025–2026 · strength 0.50
- Takahito Nakajima · 1 shared paper, 2026 · strength 0.25
- Tomoaki Furuta · 1 shared paper, 2026 · strength 0.25
- Yoshimasa Akashi · 1 shared paper, 2026 · strength 0.25
- Kentaro Hatano · 1 shared paper, 2026 · strength 0.25
- Tsuyoshi Enomoto · 1 shared paper, 2025 · strength 0.25
- Hiroaki Tateno · 1 shared paper, 2025 · strength 0.25
- Youya Nakazawa · 1 shared paper, 2024 · strength 0.17
- Akihito Machinaga · 1 shared paper, 2024 · strength 0.17
- Masaharu Murata · 1 shared paper, 2017 · strength 0.06
- Motofumi Kumazoe · 1 shared paper, 2017 · strength 0.06
- Hirofumi Tachibana · 1 shared paper, 2017 · strength 0.06
- Mai Yamashita · 1 shared paper, 2017 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.